BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16227154)

  • 1. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
    Takada K; Nagasaka K; Miyasaka N
    Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.
    Fujisawa T; Suda T; Nakamura Y; Enomoto N; Ide K; Toyoshima M; Uchiyama H; Tamura R; Ida M; Yagi T; Yasuda K; Genma H; Hayakawa H; Chida K; Nakamura H
    J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
    Harigai M; Hara M; Kamatani N; Kashiwazaki S
    Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis.
    Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T
    J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
    Wang PZ; Guan JL; Han XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis.
    Chino Y; Murata H; Goto D; Matsumoto I; Tsutsumi A; Sakamoto T; Ohtsuka M; Sekisawa K; Ito S; Sumida T
    Int J Mol Med; 2006 Jan; 17(1):101-9. PubMed ID: 16328018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
    Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
    Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis.
    Le Goff B; Chérin P; Cantagrel A; Gayraud M; Hachulla E; Laborde F; Papo T; Sibilia J; Zabraniecki L; Ravaud P; Puéchal X
    Arthritis Rheum; 2009 Jan; 61(1):108-18. PubMed ID: 19116970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    Hozumi H; Fujisawa T; Nakashima R; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Inui N; Nakamura Y; Mimori T; Suda T
    J Rheumatol; 2019 May; 46(5):509-517. PubMed ID: 30647164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.
    Kurasawa K; Nawata Y; Takabayashi K; Kumano K; Kita Y; Takiguchi Y; Kuriyama T; Sueishi M; Saito Y; Iwamoto I
    Clin Exp Immunol; 2002 Sep; 129(3):541-8. PubMed ID: 12197897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis.
    Kotani T; Makino S; Takeuchi T; Kagitani M; Shoda T; Hata A; Tabushi Y; Hanafusa T
    J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement.
    Grau JM; Miró O; Pedrol E; Casademont J; Masanés F; Herrero C; Haussman G; Urbano-Márquez A
    J Rheumatol; 1996 Nov; 23(11):1921-6. PubMed ID: 8923367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
    Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
    Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis].
    Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.